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Abstract
Background: The motif ACTAYRNNNCCCR (Y being C or T, R being A or G, and N any nucleotide), called M4,
was discovered as a putative cis-regulatory element, present 520 times in human promoter regions. Of these,
317 (61 %) are conserved within promoter sequences of four related organisms: human, mouse, rat, and dog.
Recent genome-wide studies have described M4 as a transcription factor (TF) binding site for THAP11 that
does often overlap with SBS (STAF Binding Site) a second core-promoter associated TF binding module,
which associates with the TFs STAF/ZNF143 and RBP-J. Human M4-promoter genes show enhanced
expression in cells of hematopoietic origin, especially in B lymphoblasts and peripheral blood B and T cells.
Apart from RBP-J that is well known to recruit ICN1 (the intracellular transcriptional mediator of activated
Notch1), the functional role of the hyperconserved M4 cis-element in the context of transcriptional regulation
of M4-genes in lymphoid cells remains poorly defined.
Results: Here, we present a quantitative proteomic investigation of the M4 motif TF binding landscape in
lymphoid cell lines that is further validated by ChIP experiments and functional assays. Our data strongly
suggest that THAP11 and Ikaros interact directly, while NFKB1 (NF-kappa B p50) and HCF-1 are binding
indirectly to M4-promoters in vitro and in living cells.
Further analysis reveals that M4 is a bipartite composite cis-element, which is recognized by THAP11 via
binding to the ACTAYR sequence module, thereby promoting ternary complex formation with HCF-1. Similarly,
Ikaros binds to the CCCR module of the M4 motif and this interaction is crucial for recruiting NFKB1 to M4
harboring genes. Transient reporter assays in HEK293 and loss-of-function experiments in Molt4 T cells
unequivocally demonstrate that binding of Ikaros and/or THAP11 to M4 bearing promoters is functionally
important and therefore biologically relevant. Accordingly, this study validates our SILAC-based DNA protein
interaction screening methodology as a valuable surrogate for a bona fide reverse ChIP technology.
Conclusions: The M4 motif (ACTAYRNNNCCCR) is a functional regulatory bipartite cis-element, which engages
a THAP11/HCF-1 complex via binding to the ACTAYR module, while the CCCRRNRNRC subsequence part
constitutes a binding platform for Ikaros and NFKB1.
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Abbreviations: ChIP, Chromatin immunoprecipitation; EMSA, Electrophoretic mobility shift assay;
GST, Glutathione S-transferase; HA, Hemagglutinin; HCF-1, Host cell factor-1; HEK293, Human embryonic kidney
(cells); IP, Immunoprecipitation; KD, Knockdown; LC-MS, Liquid chromatography mass spectrometry;
MT, Mutant; qRT-PCR, Quantitative real time PCR; SBS, STAF/ZNF143 Binding Site; shRNA, Short hairpin RNA;
SILAC, Stable isotope labeling with amino acids in cell culture; STAF, Selenocysteine tRNA gene transcription
activating factor; TF, Transcription factor; THAP11, Thanatos associated protein 11; TSSs, Transcription start sites;
WT, Wild-type; ZNF143, Zinc finger protein 143 (alternative name: STAF)
Background
Of the roughly 20,000 protein-coding (Genecode 25/
Ensembl 85) genes [1], there are approximately 8000 to
10,000 genes expressed at a significant level in a given
cell type. The gene regulatory code consists of the DNA
sequence-dependent binding specificities of a prominent
class of DNA binding proteins. These so called tran-
scription factors (TFs) are able to read the regulatory
information and transmit the information encoded in
primary DNA sequence to the transcriptional machinery,
thereby regulating the synthesis of RNA transcripts [2].
Differential tissue-specific gene expression is an essential
component of gene regulation in humans, which re-
stricts the expression of certain genes to given stages of
development. Importantly, the erroneous reading of the
gene regulatory code is often accompanied by the forma-
tion of tumors or the manifestation of other diseases
associated with developmental disorders. Therefore, a
detailed understanding of the spatial and temporal gene
expression patterns is of fundamental importance for
understanding the complexity of the human genome.
This is by far not a trivial task because the cis-regulatory
elements are usually ambiguous and context-dependent
and can function both in the immediate vicinity of genes
and as enhancer elements [3] thousands of DNA base
pairs away from their transcriptional start site.
Since the cis-regulatory elements and associated tran-
scription factors are believed to be responsible for main-
taining the conserved gene expression patterns between
related organisms, the elucidation of the gene regulatory
code brings back into focus a simple question: “Which
transcription factors (TFs) do bind to a cis-regulatory
element in a given cell type?”
Traditionally, TF binding to a putative cis-element
could be identified through the combination of classical
biochemical fractionations coupled to Eletrophoretic
Mobility Shift Assay (EMSA) and amino acid sequencing
of the purified transcription factors.
In order to significantly improve the traditional ap-
proach, it is essential to link the isolation and enrich-
ment of the TF directly to the detection of its sequence
specificity and its identification. Recently, we [4] and
others [5] have developed scalable methodologies [6]
that are fulfilling this task. Our SILAC-based DNA
protein interaction screen [4] makes use of the fact that
one can introduce mutational changes in the DNA se-
quence to destroy the function of a cis-element thereby
preventing the binding of its regulatory TFs. Hence, a
direct quantitative proteomic comparison of the protein
binding pattern between the natural and the mutated
DNA sequence via nanoLC-MS will provide the identity
of the TFs that have the potential to interact with the
regulatory element in vivo.
Here we apply this technology to investigate an
evolutionary hyperconserved promoter-associated cis-
element, termed M4 that until now has been poorly
studied. Briefly, a modern bioinformatic whole gen-
ome alignment comparison of mammalian genomes
(often coined “phylogenetic footprinting”) led to the
discovery of several novel, evolutionarily conserved cis-
elements, whose function was in most cases poorly char-
acterized [7, 8]. Among them the best conserved novel
element found was the M4 motif with the DNA consensus
sequence “RRACTACANNTCCCRRNRNRC.” This was
partially described as a binding site for the non-lymphoid
transcription factors THAP11, STAF/ZFN143 and RBP-J
[9, 10]. As suggested by the fact that genes harboring M4
motifs exhibit increased expression levels in lymphoid and
some leukemia or lymphoma cells [7], it implied a
putative role of M4 motif in the lymphoid system or
in hematopoietic malignancies.
In the present study, by using SILAC-based quantita-
tive proteomics, we show that the lymphocyte specific
Ikaros family proteins (Ikaros, Aiolos, and Helios), the
NF-kappa B proteins NFKB1 and NFKB2 (NF-kappa B
p50 and NF-kappa B p52), the pluripotency factor
Ronin/THAP11 and host cell factor-1 (HCF-1) are able
to bind specifically, either directly or indirectly, to the
M4 motif in vitro. Importantly, the TF M4-DNA interac-
tions of Ikaros, NFKB1 (NF-kappa B p50), THAP11 and
HCF-1 are confirmed by ChIP assays in living cells, thus
providing evidence that the SILAC-based DNA protein
interaction screen can work as a surrogate for a bona
fide reverse ChIP technology. Notably, our data also sug-
gest that the conserved M4 motif is a composite cis-
element containing two TF binding modules, which can
operate independently from each other. We provide
strong evidence that THAP11 interacts directly with the
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ACTAYR part of M4 thereby engaging in a ternary
complex with HCF-1, whereas Ikaros binds to the
CCCRRNRNRC sequence of M4. The latter inter-
action is essential for recruiting NFKB1 (NF-kappa B
p50) to the M4 motif. Transient reporter assays per-
formed in HEK 293 cells and sh-RNA mediated loss-
of-function assays in Molt4 T cells unequivocally
demonstrate binding of Ikaros and THAP11 to genes
containing M4-promoters as functional and therefore
biologically relevant. Our current model, utilizing
transient reporter assays and THAP11 shRNA knock-
down in Molt4 T cells, mainly suggests an activator
function of THAP11/HCF-1 for M4-genes in these
cells. Unlike THAP11, the apparent role of Ikaros is
to modulate the transcriptional output of endogenous
M4-harboring genes by either repressing or activating
them.
Results
EMSA assay reveals presence of M4 binding factors in
lymphocyte nuclear extracts
Although several studies have shown the binding of
some TFs to the M4 motif [9–11], none reported M4 as
the binding site for a heamatopoietic TF regardless of
the fact that genes harboring the M4 motif exhibit
higher expression levels in many cell lines derived from
the immune system [7]. EMSA was performed using a
radioactively labeled double-stranded oligodeoxynucleo-
tide bearing the M4 motif that was incubated with either
Raji burkitt’s lymphoma or Hela nuclear extracts followed
by electrophoretic separation on a native polyacrylamide
gel in order to reveal potential M4 binders that are specif-
ically expressed in hematopoietic cells. The band shift data
from Fig. 1 show the presence of lymphocyte-specific
(Raji nuclear extract) M4 binding factors that are
hardly expressed in cervical cancer HeLa cells (lane 10).
Importantly, the Raji lymphoma specific band shifts are
still formed even in the presence of a hundred-fold excess
of an unlabeled competitor oligonucleotide bearing a se-
quence unrelated to M4 (lane 7, 8, 9). Conversely, the
formation of band shifts is completely abolished if a
hundred-fold excess of non-radioactive M4 oligonucleo-
tide is added (lane 2, 3, 4, 5). This suggests that Raji bur-
kitt’s lymphoma cells express proteins that can selectively
interact with M4 motif in vitro.
MS-based proteomic screening to identify
lymphocyte-specific M4 interacting factors
To identify M4 interacting factors, Raji burkitt’s
lymphoma cells were metabolically encoded with
either “heavy” or “light” (non-radioactive) isotopic
variants of lysine (2H4 lysine/K4 or
1H4 lysine/K0).
The corresponding nuclear extracts (NEs) were pre-
pared and used as an input for subsequent SILAC-
based DNA affinity pull-down screening [4, 12, 13]
comparing the protein binding profile of M4 wild-
type (WT) versus M4 mutant baits (Fig. 2). Follow-
ing trypsin digestion and nanoLC-MS 314 out of
more than 1000 identified proteins were quantified
by the MSQuant software [14] utilizing lysine-
containing tryptic peptides. Most of the isotopic vari-
ants of quantified peptides were present in almost
equal amounts (indicated by approximate one-to-one
SILAC ratios-Fig. 2a and b). This unequivocally dem-
onstrated that most of the quantified proteins do
bind unspecifically to either M4 WT or M4 MT col-
umns. However, there were seven candidate factors
(Table 1, Fig. 2a and b), exhibiting SILAC ratios
greater than two that were termed M4-binding can-
didates (Fig. 3a).
Fig. 1 EMSA assay to uncover lymphocyte-specific transcription factors interacting with M4 motif bearing DNA. Radioactive γ-ATP labeled M4
oligo was incubated either with Raji burkitt’s lymphoma nuclear extracts (lane 2, 3, 4, 5, 7, 8, 9), or Hela nuclear extract (lane 10). EMSA complexes
formed in assays using Raji burkitt’s lymphoma nuclear extract (lane 2, 3, 4, 5) are virtually absent in Hela nuclear extract (black arrow bar). Those
band shifts were significantly faded away when an increasing amount of cold M4 motif was added (lane 2,3,4,5) but still preserved (lane 7, 8, 9) if
the cold M4 motif containing oligo was replaced by an M4 scrambled counterpart. Lanes 1, 6 are control assays using M4 oligo in the absence of
nuclear extracts
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Fig. 2 SILAC-based DNA protein interaction sreen reveals M4 binding candidates. a Distribution of SILAC ratio against quantified proteins
identified in tandem M4 DNA affinity chromatography experiments using Raji burkitt’s lymphoma nuclear extracts: The X-axis present the
random code of quantified proteins originating from the mass spectrometric screening of M4 DNA affinity chromatography experiments;
the (Y axis) present SILAC ratios of individually quantified proteins; b Mass spectra of selected M4 interacting partners’ derived peptides:
mass spectra of individual peptides comprising both light isotope (white circle) and heavy peaks (black circle). Those derived from specific
M4 binders were specified by higher intensity of heavy isotope encoded peaks. In contrast, the ones descending from unspecific binders
are presented by equal intensity of both light and heavy isotope encoded peaks (in this case PARP-1)
Table 1 Positive tandem M4 binding candidate proteins in Raji burkitt’s lymphoma cell line
M4 motif binding candidate proteins Uniprot identifier Mascot score Peptide No Peptide No used for quantification SILAC ratio
Ikaros/IKZF1 Q13422 658 16 5 >100
Aiolos/IKZF3 Q9UKT9 27 1 1 >100
Helios/IKZF2 Q9UKS7 43 2 1 >100
NFKB1 (NF-kappa B p105/50) P19838 232 8 2 19
NFKB2 (NF-kappa B p100/52 Q00653 218 6 2 31.8
HCFC1 P51610 381 9 5 19.0
THAP11 Q96EK4 37 3 1 11.0
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Immunoblot analysis confirms the in vitro interaction of
M4 binding candidates with M4
The M4 sequence of the oligodesoxynucleotide baits
used in the proteomic screening experiment were de-
rived from the DFFA gene (DNA fragmentation factor
alpha) promoter, which contains two copies of the M4
motif in close vicinity (Fig. 2 “in tandem”); however,
most human M4 bearing genes contain only one copy of
the M4 motif in their promoter [8]. To exclude the pos-
sibility that a duplicated M4 motif could induce some
avidity binding effects in respect to putative M4 interact-
ing factors, the DNA affinity chromatography was re-
peated using columns that harbor only one copy of either
WT or mutant M4 motif. Separate eluates from WT and
MT DNA columns were resolved by SDS-PAGE and sub-
jected to immunoblot analysis for validating the putative
M4-binding candidates. As shown in Fig. 3, antibodies di-
rected against Ikaros, host cell factor 1 (HCF-1), NFKB1
(NF-kappa B p50), and THAP11 confirmed the specific
binding of these proteins to the WT M4 motif (Fig. 3b).
M4-binding proteins interact with promoter regions
containing the M4 motif in vivo
To demonstrate the potential biological function of M4
motif binding candidates, classical formaldehyde cross-
linking chromatin immunoprecipitation (ChIP) assays
were performed, followed by qRT-PCR of bound DNA.
In this assay, the three M4 bearing promoters of the
genes Skp2, CDC25A, and G9A were selected for two
reasons: First, gene ontology analysis of M4-genes reveal
that genes involved in mitotic cell cycle regulation and
chromatin function are statistically overrepresented
amongst M4 bearing genes (data not shown). Second,
expression levels of the three aformentioned genes were
significantly affected upon ectopic over-expression of the
dominant negative Ik6 isoform [15] of Ikaros in Raji bur-
kitt’s lymphoma cells as well as Molt4 T-cells (data not
shown). Initial attempts to establish ChIP conditions for
Ikaros in Raji burkitt’s lymphoma cells employing anti-
bodies directed against the Ikaros C-terminus were difficult
and could be ascribed to the fact that Raji burkitt’s lymph-
oma cells exhibit an abundant expression of small Ikaros
isoforms (data not shown), which are not able to bind
DNA directly but can multimerize with IK1 and Ik2 (DNA
binding) isoforms. Such higher-order complexes cannot be
efficiently recovered by the standard ChIP protocol, which
works under stringent denaturing conditions strongly
favouring the recovery of DNA sequences that are directly
crosslinked to the immunoprecipitated protein.
To circumvent this, we decided to focus on T-lymphoma
Molt4 cells because these cells do not express the small
Ikaros isoforms (data not shown). Furthermore, to
standardize our IP conditions, C-terminally HA-tagged
Ikaros that is known to recognize canonical Ikaros target
genes [16] was constructed and retrovirally transduced into
Molt4 cells (Ikaros-HA transduced cells are termed Molt-
IK-HA hereafter). A similar procedure was adopted for the
generation of Molt4-THAP11-HA cells, which ectopically
expresses C-terminally HA-tagged THAP11 protein. Im-
portantly, like its endogenous counterpart, THAP-11-HA
demonstrates robust M4-specific binding in a DNA af-
finity pulldown assay (Additional file 1: Figure S1).
The two HA-tagged transgenic Molt4 T-cell lines were
later used for either Ikaros or THAP11 ChIP assay using
a high affinity rat-anti-HA antibody (3 F10). As seen
in Fig. 4a, M4 motif-bearing DNA was specifically
Fig. 3 Immunoblot analysis to confirm the specific binding of Ikaros, HCF-1, NFKB1 (NF kappa B p50) and THAP11 to the mono M4 motif-containing
DNA affinity column. a prominent putative M4 binding candidate factors. b DNA affinity chromatography: M4 WT and control mono M4 MT were
immobilized as ligand, Raji burkitt’s lymphoma nuclear extract was used as input. Protein-DNA complexes from two columns were eluted, resolved by
SDS-PAGE separately for Western blotting analysis. Specific antibodies were used to detect the retention of suspected M4 binding candidates. The
unspecific DNA binding factor TPB was adopted as loading control: (Abbreviation: FT-WT M4/flow-through M4 wild type, FT-M4-MT/ flow-through M4
mutant, E M4-WT/ eluate M4 wild type, E M4 –MT/ Eluate M4 mutant)
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Fig. 4 Chromatin Immunoprecipitation (ChIP) analysis of Ikaros, NFKB1 (NF-kappa B p50), THAP11, and HCF-1 binding to M4-bearing promoters of
the genes Skp2, CDC25A, and G9a. Formaldehyde crosslinked chromatin of Molt-IK-HA or Molt4-THAP11-HA cells were sheared by ultrasonication
into an average length of 300 to 1000 bps to be subjected to immuno-precipitation assays using anti-NF-kappa B p50, anti-HCF-1, anti-HA/Ikaros,
anti-HA/THAP11, or preimmune IgG sera (control). The TF-associated chromatin were analyzed via quantitative real time PCR (qRT-PCR) using
primer sets flanking the suspected TF binding site and background binding control regions: Promoter (M4 motif), Exon (exon control), ±2000 bp
(control regions downstream and upstream from the corresponding M4 cis-element). Enrichment of TF-bound DNA amount were normalized to
corresponding amount in input. ChIP results (average of three technical replicates) for Ikaros (a), NFKB1 (NF-kappa B p50) (b), THAP11 (c) and
HCF-1 (d) are shown
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co-precipitated by anti-Ikaros/HA IP (compared with
IgG control serum), demonstrating specificity of the
IP protocol. Strikingly, binding of Ikaros to chromatin was
selectively enriched on DNA fragments containing the M4
motif in all three promoters examined (Skp2, CDC25A,
and G9a). Therefore, it can be concluded that Ikaros inter-
acts with the M4 cis-element in living cells. Recapitulating
the same experimental strategy, we were able to show the
specific and selective enrichments of NFKB1 (NF-kappa B
p50) (Fig. 4b), THAP11-HA (Fig. 4c) and HCF-1 (Fig. 4d)
on the promoters of the M4 bearing genes Skp2,
CDC25A, and G9a.
Intriguingly, ChIP enrichment of NFKB1 (NF-kappa B
p50) bound interleukin-2 promoter DNA, which repre-
sents a well established NF-kappa B target gene harbor-
ing a classical palindromic kappa B binding site [17, 18],
was comparable to the enrichment of NFKB1 (NF-kappa
B p50) bound M4-promoter DNA (Fig 4b). This sug-
gested that the affinity of NFKB1 (NF-kappa B p50) to-
wards M4-bearing promoters was not substantially
different compared to a well studied classical NF-kappa
B target gene.
M4 motif is a composite element, comprising two distinct
non-overlapping binding sites for both THAP11 and
Ikaros
According to our studies the M4 motif consists of
two highly conserved parts. While the “upstream
core” RRACTAYR is similiar to the Ronin (murine
THAP11 orthologue) binding site, the “downstream core”
(TCCCRRNR) is similar to the previously described mur-
ine Ikaros binding site consensus (YCTCCCARR) [19].
This raises the question if the M4 motif is indeed a com-
posite element that can be partitioned into two sub-
consensus sequences. The latter can be best answered by
investigating if the suspected direct sequence-specific
interaction partners of the M4 cis-element, THAP11 and
Ikaros, are binding synergistically or independently to M4.
Therefore, we hypothesized that the “downstream
core” (TCCCRRNR) will be sufficient to recruit Ikaros,
whereas the “upstream core” RRACTAYR would be in-
dispensable for engaging other M4 binders namely
THAP11. To verify this, oligo-pulldown assays were
conducted using three modified M4 motif-bearing DNA
sequences as a ligand: Mod-M4 (the very flanking
nucleotides of the M4 motif were mutated), F-MT-M4
(for which the “upstream core” RRACTAYR of M4 motif
was mutated), and R-MT-M4 (the “downstream core”
TCCCRRNR of M4 motif was mutated). As can be seen
in Fig. 5, the “flanking” mutations did not interfer with
the binding of either M4 binding factors to the M4
motif. In contrast, the mutation of the M4 “upstream
core” RRACTAYR was sufficient to simultaneously abro-
gate the binding of THAP11 and HCF-1 to M4 motif
bearing DNA, while still preserving the interaction of
both Ikaros and NFKB1 (NF-kappaB p50) with the M4
motif. Consequently, mutation of the “downstream” part
of the M4-motif abolished recruitment of Ikaros and
NFKB1 (NF-kappaB p50) to M4 DNA, but did virtually
not alter the binding of THAP11 and HCF-1 to M4. For
this reason we conclude from our in vitro binding data
that M4 is a composite TF binding module. It consists of
two TF binding sites; the “upstream core” RRACTAYR
that is essential for recruiting THAP11/HCF-1 to the
M4 cis-element and the “downstream core” TCCCRRNR
that is required for establishing M4-Ikaros/NF-kappa B
interactions.
NFKB1 (NF-kappa B p50) interaction with M4 is critically
dependent on Ikaros
The M4 motif is neither a palindromic sequence nor
analogous to any known kappa B site [17, 18]. However,
the “downstream core” (TCCCRRNR) that mediates
NFKB1 association is highly similar to the murine Ikaros
binding site. Therefore, one of two scenarios can be
a
b
Fig. 5 The M4 motif is a bipartite composite element, consisting of
two independent binding site modules for THAP11 and Ikaros. a
DNA ligands used in affinity chromatography: mono-M4 wild-type
(WT), mono-M4 mutant (MT), Mod-M4 (the very flanking nucleotides
of the M4 motif are modified), F-MT-M4 (the core” RRACTAYR of M4
motif was modified) and R-MT-M4 (the “downstream core”
TCCCRRNR of M4 motif were modified). b Immunblot analysis of
DNA affinity chromatography experiments using five DNA ligands:
Input (Molt4 nuclear extract) and eluates from three columns were
resolved by SDS-PAGE in parallel and subjected to Western blotting.
Specific antibodies detected the retention of suspected M4
binding factors
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envisioned: i) Ikaros and NFKB1 compete in binding to
the “downstream core” (TCCCRRNR) of the M4 motif
or ii) NFKB1 is recruited to the M4 motif in an Ikaros-
dependent manner. To investigate this a stable shRNA
Ikaros knock-down Molt4 cell line (named Molt4-IK-KD
in the following) was generated by retroviral transduction,
in which Ikaros protein expression was almost completely
abrogated (Fig. 6a, input Molt4-IK-KD). DNA affinity
chromatography experiments using mono-M4 WT and
mono-M4 MT beads in combination with nuclear extracts
from Molt4 (control), Molt4-IK-KD or cells that do not
express Ikaros (human embryonic kidney HEK 293 cells,
Fig. 6b) were conducted and subjected to immunblot ana-
lysis as described before. Notably, even though protein ex-
pression levels of NFKB1 (NF-kappa B p50) were virtually
not affected by our highly efficient Ikaros knockdown, its
binding to the M4 column was completely abolished.
However, upon ectopic expression of Ikaros in HEK293
Fig. 6 NFKB1 (NF-kappa B p50) interacts with Ikaros and this interaction is essential for recruiting Rel-NF-kappa B family TFs to M4 motif harboring
DNA. a Immunoblot analysis of DNA affinity chromatography experiments using two DNA ligands: mono-M4 WT and mono-M4 MT. Molt4 control
or Molt4-Ikaros KD nuclear extracts served as input. In the absence of Ikaros, protein levels of NFKB1 (NF-kappa B p50) were virtually not affected
(lane 4 vs 1) but its binding to the M4 column was completely abrogated (lane 5). In contrast, the binding of the two other established M4-binders
(THAP11 and HCF1) were robustly maintained (lane 2 and 6). b Anti-NF-kappa B p50 (NFKB1) IP (immunoprecipitation) co-precipitated Ikaros in the
presence (lane 4,5) and absence (lane 2, 3) of the highly efficient nuclease bezonase. c Cross-linked streptactin pulldown experiment
demonstrates co-purification of StrepII-tagged Ikaros (see the text) with NFKB1 (NF-kappa B p50) protein (lane 4), whereas the nuclear
protein kinase CDK9 that was reported to interact with NFKB1 (NF-kappa B p50) (see text) was not present in the cross-linked complex
(compare lane 1, 2 with 3, 4). d Benzonase nuclease digestion control assay: the control 40 bp duplex DNA or control salmon sperm
DNA were mixed with Molt4 nuclear extracts in the presence or absence of benzonase at 4 °C (5 h to overnight). The whole
samples were analyzed by an 8 % (19:1) native TBE-PAGE gel that allows separation of DNA down to the size of 10 bps
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cells (Fig. 6c), the recruitment of NFKB1 (NF-kappa B
p50) to M4 containing DNA was reestablished. In con-
trast, the binding of the two other M4-binders (THAP11
and HCF1) was not affected either by the absence (Fig. 6a
and b, Molt4-IK-KD) or presence (Fig. 6b and c) of Ikaros
expression. This implies that Ikaros expression is abso-
lutely crucial for the binding of NFKB1 (NF-kappa B p50)
to DNA harboring the M4 sequence in vitro. Nevertheless,
it remained to be resolved if NFKB1 (NF-kappa B p50)
was recruited to M4 by a more direct interaction with
Ikaros. To address this, we have carried out a coimmuno-
precipitation assay using anti-NFKB1 (NF-kappa B p50)
antibody. The results clearly demonstrate that Ikaros is
part of a NFKB1 (NF-kappa B p50) protein complex,
which is resistant to efficient (Fig. 6f) DNA and RNA nu-
clease (benzonase) digestion (Fig. 6d). Of note, the latter
indicates that the Ikaros containing NFKB1 complex is
not formed or stabilized by random protein nucleic-acid
interactions.
To exclude the possibility that Ikaros might unspecifi-
cally associate with the anti-NFKB1 (NF-kappa B p50)
serum, a reverse immunoprecipitation assay using either
anti-Ikaros or anti-HA (Molt-IK-HA cells) antibodies
was conducted. However, co-precipitation of NFKB1
(NF-kappa B p50) was not achieved (data not shown).
Since both the anti-Ikaros and anti-HA antibody
recognize epitopes at the C-terminus of Ikaros, which is
known to mediate protein-protein interactions [20], we
reasoned that antibody binding to the Ikaros carboxyter-
minus might disturb the Ikaros-NFKB1 (NF kappa B
p50) interaction.
To circumvent this, an aminoterminal tag was fused
to the cDNA of human Ikaros (Additional file 1:
Figure S2). The tandem-StrepII-tag (StrepOne tag)
was selected as it exhibits an extremely fast on-rate
during binding to Streptactin beads and chromatog-
raphy can be performed under very stringent condi-
tions employing formaldehyde crosslinking. In order
to pursue this, a Molt4 cell line stably expressing
StrepII-tagged Ikaros (Molt4-strep-tagged-Ikaros cells)
was created via retroviral transduction. To confirm
that the heterologously expressed StrepII-tagged Ikaros
protein is functional, ChIP experiments were conducted
as described above. The ChIP enrichement values for se-
lected M4-bearing gene promoters (Skp2, CDC25A, and
G9a) were almost identical (Additional file 1: Figure S2) to
the ones obtained with Ikaros-HA protein (Molt-IK-HA
cells, Fig. 4a) suggesting that ectopically expressed
StrepII-tagged Ikaros retains its biological function.
As seen in Fig. 6e, the crosslinked Streptactin pull-
down experiment reveals a moderate (but highly specific
and reproducible) co-purification of NFKB1 (NF-kappa
B p50) protein with StrepII-tagged Ikaros, whereas the
nuclear protein kinase CDK9 that was reported to
directly interact with NFKB1 (NF-kappa B p50) [21] was
not present in the crosslinked complex. This demon-
strates high specificity of the formaldehyde crosslinking
approach (e.g. avoiding “over”-crosslinking). Since the
benzonase treatment proved to be very efficient in re-
moving nucleic acids from the input fraction (Fig. 6f ), it
could be inferred that the Ikaros-NFKB1 (NF-kappa B
p50) complex formation most likely involves protein-
protein contacts and is not unspecifically mediated by
random DNA or RNA. Hence, we conclude (Fig. 6) that
a minor fraction of nuclear NFKB1 (NF-kappa B p50) is
able to engage with Ikaros and that this interaction is
most likely essential for recruiting NFKB1 to M4 motif
containing DNA in vitro. Importantly, the data do not
rule out the possibility that the Ikaros-NFKB1 (NF-kappa
B p50) interaction can be enforced upon binding to M4
DNA, either by an allosteric effect transmitted through a
conformational change of Ikaros upon DNA binding or by
(sequence-independent) DNA-contacts mediated by the
Rel homology domain of NFKB1 (or both).
Ikaros knock-down does not influence the M4 motif
binding of THAP11 and HCF-1 in vivo
To confirm that the M4 motif does also operate in vivo
as a composite element, which assumes that the Ikaros/
NFKB1 (NF-kappa B p50) complex does not influcence
the binding of THAP11/HCF-1 to M4-gene promoters,
we performed ChIP in Molt4 and Molt-IK-KD cells, re-
spectively (as seen in Fig. 7a and b). In the absence of
Ikaros expression (Molt-IK-KD cells), the enrichment of
NFKB1 (NF-kappa B p50) at three representative M4
bearing promoters (Skp2, CDC25A, and G9a) was totally
abrogated (Fig. 7c), whereas binding of either THAP11
or HCF-1 did not change substantially. Consequently,
these data together with the results depicted in Fig. 6
lead us to conclude that the M4 motif also constitutes in
vivo a composite cis-element, with distinct and inde-
pendent THAP11/HCF-1 and Ikaros/ NFKB1 binding
modules.
THAP11 interacts with HCF-1 via its C-terminal domain,
which is required for tethering HCF-1 to M4 motif
containing DNA
Towards this end we could show that HCF-1 is a bona
fide component of M4 motif-binding complexes. How-
ever, HCF-1 is not known to be a sequence-specific DNA
binding factor but primarily contacts DNA through asso-
ciation with other TFs, such as the Oct1 protein [22] and
Ronin-the mouse orthologue of THAP11 [10, 11, 23]. In
order to examine if this interaction is also taking place in
the context of human proteins, a GST-pulldown assay was
carried out using Molt4 nuclear extracts as input. Briefly,
the cDNA encoding either full-length or the carboxyterm-
inal part of human THAP11 (encompassing the last 116
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amino-acids) were cloned in-frame downstream of a
glutathione-S-transferase gene (GST) cassette and expressed
in E. coli. Subsequently, the purified GST-fusion proteins
were used as bait for identifying THAP11-interacting part-
ners from Molt4 nuclear extracts in GST pull-down as-
says. In this context glutathione-sepharose beads loaded
with GST only served as a negative control.
As illustrated in Additional file 1: Figure S3, homoge-
nously purified GST-fusion proteins were obtained
(lower panel) that efficiently and specifically captured
HCF-1 protein as visualized by immunoblot analysis
(upper panel). This result could also be confirmed in an
independent proteomic experiment using LC-MS-based
protein identification (data not shown). Therefore, we
infer that the carboxyterminal domain of THAP11 inter-
acts quite strongly with HCF-1 in human cells, an
interaction potentially crucial for tethering HCF-1 to M4
motif-bearing DNA.
Binding of Ikaros and THAP11 to a M4 motif containing
promoter is functional in transient reporter assays
Until now we demonstrated that in lymphocytes, THAP11
and Ikaros independently interact with M4 cis-elements
in vitro as well as in living cells. However, it is equally im-
portant to assess if M4-binding plays a functional role in
regulating gene expression of M4-harboring genes. As a
functional readout, we first established a reporter assay
system using HEK 293 cells, in which, a set of artificial
M4 and M4 mutant-bearing promoters could be studied
for their regulatory potential to drive expression of a
downstream-conjugated luciferase gene reporter. As dis-
cussed above HEK293 cells do not possess any detectable
Ikaros expression but ectopic expression is easily accom-
plished by transient transfection. As already described in
Fig. 6b and c, ectopically expressed Ikaros displays specific
M4 binding in vitro and additionally induces the recruit-
ment of NFKB1 (NF-Kappa B p50) to M4 WT baits.
To assay the transcriptional activity of an M4-bearing
promoter, a well-characterized luciferase reporter (com-
prising the Xenopus tRNASec promoter) was selected,
which accommodates a functionally validated binding
site for the ubiquitiously expressed transcriptional acti-
vator STAF (ZNF143) [24]. The latter fits to the STAF
consensus binding sequence (SBS) YWCCCRNMATSC-
MYYRCR (Y, W, R, N, M, and S stand for T/C, A/T, A/G,
any nucleotide, A/C, and G/C, respectively). This sequence
Fig. 7 Chromatin Immunoprecipitation (ChIP) analysis of NFKB1 (NF-kappa B p50), THAP11 and HCF-1 interaction with M4 genes in Ikaros knockdown
cells. Formaldehyde crosslinked chromatin of Molt4 or Molt4-IK-KD cells was sheared by ultrasonication into an average length of 300 to 1000 bps and
ultimately subjected to immuno-precipitation assays using a anti-THAP11 antibody, b anti-NF-kappa B-p50 (NFKB1) antibody, c anti HCF-1, or preim-
mune IgG sera (control). The TF-associated chromatin were analyzed via quantitative real time PCR (qRT-PCR) using primer sets flanking the promoters
(M4 motif), and gene body control regions (Gene body) of M4-bearing Skp2, CDC25A, and G9a genes; d the known NFKB1 (NF-kappa-B p50) target
genes Vcam-1, HLA-B were also included as control. Enrichment of TF-bound DNA amount were normalized to corresponding amount in input. ChIP
results (average of three technical replicates) for NFKB1/NF-kappa B p50 (c), THAP11 (a), and HCF-1 (b) were shown
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was fused at its 5′-position with the sequence of the M4
motif, which is frequently overlapping with SBS in mamma-
lian promoters [24]. Hence, the resulting synthetic pro-
moter sequence (ACTACAATTCCCATTATGCCCCGCG)
comprises the following regulatory modules: ACTACA
(THAP11-binding site), TCCCATTA (Ikaros-binding site)
and TCCCATTATGCCCCGCG (SBS, STAF-binding site;
Fig. 8a: depicted as X and highlighted in green). Addition-
ally, each reporter construct contains two copies of the
regulatory module that encompasses either the M4 WT
motif (Fig. 8c, sequence O and Q) or mutated M4 variants
(sequences P, R and S).
As seen in Fig. 8b, Ikaros expression (black bars) cor-
relates with a twofold reduction in luciferase activity
(reporter constructs O, P and Q). Importantly, the re-
pressive activity is absolutely dependent on the presence
of an intact Ikaros binding site (compare reporter con-
structs R and S with O, P and Q).
To confirm this observation, the two M4-reporter con-
structs that harbor mutated (GCG to TAC mutation at
the 3′ end) STAF/ZNF143 binding sites, namely reporter
Q (intact Ikaros binding site) and sequence R (mutated
Ikaros binding site) were selected in order to alleviate
the profound transcription stimulatory activity of STAF/
ZNF143 (Fig. 8b and c). Then a transient reporter assay
was performed expressing increasing amounts of Ikaros
(Fig. 8d).
These data (Fig. 8d) clearly demonstrate that Ikaros is
repressing reporter gene activity in a strictly dose-
dependent manner because Ikaros protein expression
level was inversely correlated to transcriptional activity
of the M4-reporter Q (Fig. 8d, assays 1 to 3). Conversely,
upon Ikaros binding site mutation (M4-reporter R) the
repressive effect of Ikaros was completely abrogated
(Fig. 8d, assays 4 to 6).
Mutation of the THAP11 binding site diminished re-
porter gene activity by at least two-fold, both in the
presence and absence of Ikaros protein (compare re-
porter constructs O and P in Fig. 8b).
In summary, in the context of our transient-reporter
assays, Ikaros acts as a transcriptional repressor, whereas
THAP11 does function as an activator.
Ikaros knockdown results in de-regulated expression of
M4-harboring genes
So far, it was demonstrated that Ikaros is able to regulate
the transcriptional output of M4-bearing genes in the
context of a transient reporter assay. However, it is not
known if Ikaros might play a critical role in gene regula-
tion of endogenous M4-harboring genes. To determine
Fig. 8 A luciferase M4-reporter assay system to study the functional role of Ikaros for M4-harboring genes. a Scheme illustrating the modular M4-
reporter gene. The M4 motif is composed of a THAP11 binding site (ACTAYR, purple) and an Ikaros binding site (TCCCRR), yellow) which overlaps
with the binding site of the transcriptional activator STAF/ZNF143 (factor-X in green). b M4-reporter gene activity (indicated as relative luciferase
units) of M4-WT compared to mutated M4-variant promoters in HEK 239 and HEK293-Ikaros cells, which are stably expressing heterologous Ikaros.
Transcriptional activity of corresponding M4-promoters in the absence (black bars) or presence (white bars) of Ikaros. Immunoblot analysis measuring
Ikaros protein expression levels and input loading control (tubulin alpha) c Nucleotide sequence presentation of the M4-modules and its variants used
for M4-reporter gene assays. d Transient luciferase reporter assay employing M4-reporter Q and R (details: panel c). Ikaros is repressing M4-reporter Q
in a dose-dependent manner
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this, the RNA from Molt4 Ikaros knockdown cells
(Molt-IK-KD; described above) and Molt4 control cells
(Molt4 mock) were used for quantitative RT-PCR exper-
iments in order to monitor the changes in gene expres-
sion of selected M4 bearing genes. As seen in Fig. 9, the
knockdown of Ikaros did not affect THAP11 mRNA
levels significantly. In contrast, it substantially increased
the mRNA amount of some well established Ikaros tar-
get genes (lacking M4 sequences), like the B cell-specific
lambda5 [16] or T cell-specific Hes1-gene, for which
Ikaros is known to function as a transcriptional repres-
sor [25, 26]. In parallel, the Ikaros knockdown dramatic-
ally reduces the expression level of the Ikaros family
gene Aiolos, for which Ikaros serves as an important
transcriptional activator [27]. Apart from affecting known
Ikaros target genes, depletion of Ikaros caused both
up-regulation (Skp2, CDK9 and Hexim1) and down-
regulation (CDC25A, AAMP) of selected M4-harboring
genes (Fig. 9). In addition, the M4-genes G9a and MLL4
did not virtually change expression. Similar results were
obtained from a comparative microarray analysis of
Molt-IK-KD versus Molt4-mock cells (data not shown).
In conclusion we propose that Ikaros can modulate the
activity of M4-harboring genes in living cells.
THAP11 knockdown leads to weak but significant
changes in gene expression of selected M4 motif
harboring genes
Finally, for deciphering the biological and functional
relevance of the THAP11-M4 motif interaction in living
cells, a stable (shRNA) THAP11 knockdown cell was
generated (Molt4-sh-THAP11). However, it seems that
THAP11 might be essential for cell viability, because
selection of clones that exhibited both a complete abla-
tion of THAP11 mRNA levels and a substantial decrease
in THAP11 expression was not possible (Fig. 10a). It
was noted that THAP11 localizes to both the cytoplasm
and nucleus (Fig. 10b and data not shown). Surprisingly,
the knockdown mainly affected its cytosolic fraction
while keeping a reduced, but still substantial amount of
THAP11 in the nucleus (Fig. 10b). As for this reason,
strong effects of the THAP11 knockdown on M4 target
gene expression were not expected. To provide reprodu-
cible data it was decided to conduct biological replicate
experiments in which the extraction of Molt4-sh-THAP11
total mRNA was carried out at two different time points
(with a time gap of 2 weeks) after selecting the clone.
These samples are termed biological replicate 1 and bio-
logical replicate 2, respectively.
As seen in Fig. 10c, the biological replicate 1 (red bars)
of Molt4-sh-THAP11 transcript exhibits a ten-fold re-
duction of THAP11 mRNA that correlates with the
down-regulation of most selected M4 bearing genes.
This is in accordance with previous observations made
in transient reporter assays (Fig. 9) and suggests that
THAP11 works as a transcriptional activator in control-
ling M4 motif-bearing genes. Two weeks after the first
mRNA extraction, biological replicate 2 (yellow bar) of
Molt4-sh-THAP11 mRNA preparation was performed.
The quantitative PCR (qPCR) analysis of the second
mRNA extraction revealed reproducible effects of
THAP11 protein reduction on the transcript levels of
CDC25A, Skp2, CDK9, Mll4, and G9a, whereas the
influence of THAP11 on gene expression levels of
Hexim1 and AAMP was quite variable.
Discussion and conclusions
The motif M4 ACTAYRNNNCCCR (Y being C or T, R
being A or G, and N as any nucleotide) was discovered
by Xie and colleagues in 2005 [7] as a putative cis-
regulatory element. This motif was described to be
highly conserved in a window from less than 2500 bps
upstream and 500 bps downstream of transcription start
sites (TSSs) of many annotated genes of human, mouse,
rat, and dog with a peak centered around − 89 bp from
TSSs. Hence, the hyperconserved M4 motif can be con-
sidered as a core-promoter associated cis-element that
can be found on 520 human genes, implying a potential
important role in regulating multiple cellular processes.
Recently, by using ChIP-Seq assays combined with
bioinformatics, two independent groups [9, 11] have
demonstrated M4 motifs as binding site for RBP-J and
ICN1 (activated Notch1), as well as STAF/ZNF143, and
THAP11 (also known as Ronin in mouse), mostly in
context of non-lymphoid cells like HeLa, HEK293, K562
and murine ES cells. However, according to the initial
publication by Xie and colleagues, genes bearing the M4
Fig. 9 Ikaros loss-of-function (knockdown) leads to de-regulated
expression of M4 bearing genes. The mRNA level (normalized to
GAPDH mRNA amount) fold change of known Ikaros target genes
(green box) and of selected M4 bearing (red box) genes is shown
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motif are preferentially expressed in human cells of
hematopoietic origin (e.g. B lymphoblasts, peripheral
blood CD19 B cells as well as CD4 and CD8 T cells),
which prompted us to revisit and comprehensively
characterize the M4 TF binding landscape in lymphoid
cell lines.
In order to pursue this we employed our SILAC-based
DNA protein interaction screening method, which we
showed to be technically capable of uncovering direct
and indirect (“piggy-back”) TF cis-element interactions
[4]. In this respect, our motivation was twofold. First of
all, we wanted to make use of the partially studied M4
model with the aim of demonstrating that our quantita-
tive proteomic methodology [4] is working as a surro-
gate for a bona fide reverse ChIP technology. Second, we
intended to screen for M4-binders in an unbiased man-
ner exclusively utilizing the M4 sequence logo [28] infor-
mation derived from Xie and colleagues [7], thereby
avoiding issues with the overlap of M4 with SBS (STAF/
ZNF143 Binding Sequence [9]). Building on that, in this
proteomic study, we successfully identified the nuclear
factors THAP11, HCF-1, Ikaros, Aiolos, Helios, NFKB1
(NF-kappa B p50) and NFKB2 (NF-kappa B p52) as
interacting partners of the M4 motif in the context of a
human lymphocyte nuclear extract (Figs. 2 and 3). Lim-
ited by the availability of reagents we conducted follow-
up experiments for THAP11, HCF-1, Ikaros and NFKB1.
Importantly, we demonstrated that at least in lympho-
cyte cell lines, M4 is functioning as a bipartite composite
element, in which the “upstream” ACTAYR part
Fig. 10 THAP11 knockdown leads to weak but significant changes in selected M4 bearing gene expression. a left panel shows fold reduction of
THAP11 mRNA upon shRNA-THAP11 knockdown, right panel shows Western blot analysis of THAP11 protein from whole cell extract (WCE) of
Molt4 THAP11 knockdown (shTHAP11) or "Mock" Molt4 cells (control); the amount of DNA polymerase delta cofactor PCNA was visualized by its
specific antibody and served as SDS-PAGE “loading control”. b Cytosol and nuclear extract of Molt4 THAP11 knockdown (shTHAP11) or "Mock"
Molt4 cells was subjected to immunoblot analysis to investigate the reduction of THAP11 protein level c Fold change of selected M4-gene
expression levels upon THAP11 knockdown. Violet bar: M4-gene mRNA levels of control cells (mock Molt4) is normalized to one. Purple bar: fold
change of M4-gene mRNA levels of Molt4 THAP11 knockdown cells extracted right after establishing the shTHAP11 clone (biological replicate 1). Yellow
bar: fold change of M4-gene mRNA levels measured from biological replicate 2 (mRNA preparation 2 weeks after biological replicate 1) of Molt4
THAP11 knockdown cells
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constitutes a binding site for the TF THAP11, while the
“downstream” CCCR module provides the direct DNA
contact for the lymphocyte specific TF Ikaros. Most
probable and similar to Ikaros, Helios and Aiolos might
also play a modulatory role for certain M4 genes, but it
is very difficult to investigate their function because
Ikaros itself serves as a master regulator of Aiolos and
Helios gene transcription (Fig. 9, [27]). Nevertheless, it
would be interesting to investigate this further because
Ikaros and Helios can have opposite functions at the
same target gene [29]. In our model (Fig. 11) and building
on our data discussed below the epigenetic factor HCF-1
is recruited to M4 motif DNA by virtue of its interaction
with the THAP11 C-terminal domain (Additional file 1:
Figure S3), whereas the Rel/NF-kappa B-factors (NFKB1/
NF-kappa B p50 or NFKB2/NF-kappa p52) are strongly
believed to be tethered to the M4 element in an Ikaros-
dependent manner (Fig. 6). These findings indeed verify
the power of the SILAC-based DNA protein interaction
screening methodas a comprehensive approach, which
can capture direct and indirect DNA-TF assemblies. In
contrast, the limitation of EMSA is seen in Fig. 1, for
which EMSA was carried out with Raji nuclear extracts.
The latter showed at least two strongly retarded (shifted)
bands that are virtually absent in HeLa nuclear extracts,
albeit THAP11 and HCF-1 are equally well expressed in
HeLa cells (data not shown). This is surprising because
bacterially expressed THAP11 [9] is able to retard
radioactive-labelled DNA sequences bearing the M4
motif in conjuction with the SBS element. This
phenomenon could be explained by the lack of lympho-
cyte specific factors in Hela nuclear extracts that together
with THAP11 and HCF-1 might be responsible for higher
order complex formation.
Ikaros and NF-kappa B proteins are direct DNA bind-
ing factors whose canonical binding or half sites [17] are
similar to the CCCR module of M4 motifs. However in
nuclear extracts prepared from cells that do not express
Ikaros (HEK293, HeLa) the binding of NFKB1 (NF-
kappa B p50) to M4 could not be detected. Interestingly,
the binding of NFKB1 to the “downstream” module of
M4 was clearly restored upon heterologous expression
of Ikaros in HEK293 cells (Fig. 6c), suggesting an essen-
tial role of Ikaros protein in tethering NF-kappa B
proteins to M4. This was further corroborated in experi-
ments that utilized an Ikaros knockdown Molt4 cell line,
which does not express any Ikaros as assessed by west-
ern blotting (Fig. 6a). Employing nuclear extracts from
these KD cells revealed that recruitment of NFKB1 (NF-
kappa B p50) to M4 DNA was completely abrogated,
while binding of THAP11 and HCF-1 was essentially
not affected (Fig. 6a). Beyond this, Ikaros KD cells do
also loose expression of Helios and Aiolos at least at the
mRNA level (Fig. 9). Therefore, it will be interesting to
test in future experiments if Helios and Aiolos are also
capable to promote NFKB1 binding to M4. The
Fig. 11 Working model for the assembly of M4 binding factors on promoters of M4 genes. The M4 motif is composed of two highly conserved
elements: an “upstream” ACTACR module (purple) and a “downstream” module TCCCRR (yellow), which constitute bipartite binding sites for
THAP11 and Ikaros, respectively. Interaction between THAP11 and HCF-1 is required for recruiting HCF-1 to the M4 motif, whereas an interaction
of Ikaros with NFKB1 (NF-kappa B p50) or NFKB2 (NF-kappa B p52) is essential for tethering these Rel TF family proteins to the M4 motif
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observations discussed above were further recapitulated
by ChIP assays performed in Molt4 Ikaros KD cells.
More precisely, the presence of NFKB1 (NF-kappa B
p50) at M4 motif harboring promoters was severely
compromised (Fig. 7c), whereas recruitment of THAP11
and HCF-1 was still preserved (Fig. 7a and b).
It could therefore be inferred that NFKB1 (NF-kappaB
p50) is recruited to M4-genes in an Ikaros dependent
manner. Mechanistically, this is probably taking place by
the formation of Ikaros-NFKB1 protein complexes that
we detected by coimmunoprecipitation of Ikaros
employing an anti-NFKB1 antibody and copurification
of NFKB1 (NF-kappa B p50) with StrepII-tagged Ikaros,
respectively (Fig. 6c and d). Since we did not carry out
in vitro binding studies with recombinant Ikaros and
NFKB1 proteins it is formally still possible that their
interaction is either indirect or heavily dependent on the
presence of M4 containing DNA/chromatin. Further-
more, we cannot rule out the possibility that Ikaros KD
has an additional influence on NF-kappa B signaling,
eventually resulting in a decreased ability of NFKB1 to
bind to DNA/chromatin (Fig. 7d). Based on the results
obtained from reporter assays and Ikaros loss-of-function
(Ikaros KD) experiments we are confident that the associ-
ation of Ikaros with hyperconserved M4 elements is func-
tionally relevant (Figs. 8 and 9). However, an elucidation
of the detailed mechanistic action of Ikaros (and NFKB1)
in governing the transcriptional output of M4 bearing
genes might be gene-specific [30] and was outside the
scope of this manuscript. As described for the negative
cross-talk between STAF/ZNF143 and RBP-J-ICN1 het-
eroconjugates [9], Ikaros-NFKB1 complexes could simi-
larly compete with M4 binding of STAF/ZNF143 and/or
RBP-J, especially in light of the fact that at the genome-
wide level Ikaros and RBP-J are generally sharing the same
short binding consensus [31]. Together this could also
mean that the transcriptional output of M4 genes can be
modulated by a complex interplay of relative expression
levels of Ikaros, Helios, Aiolos and RBP-J that is further
orchestrated by the status of Notch1 and NF-kappa B
pathway signaling inputs. At this instance, it has been re-
ported that NFKB1 (NF-kappa B p50), which in contrast
to RELA/NFKB3 (NF-kappa B p65) is lacking a classical
transactivation domain, can be found in N-CoR corepres-
sor complexes. Upon interleukin-1 beta stimulation the
promoter occupancy of N-CoR corepressor complex at
NFKB1 bound promoters is abolished, which is followed
by recruitment of Tip60 coactivator complexes and a
subsequent change in the gene expression program
[32, 33]. Interestingly, our Ikaros interactome from
Molt4 cells (unpublished results) contains various
corepressors (RCOR1/CoREST, RCOR3, NuRD) along
with NFKB1 and NFKB2, while THAP11 and HCF-1
are absent.
Collectively, we would like to propose the current
working model for M4 function in lympocytes that is
depicted in Fig. 11. In accordance to previous findings
[10, 11] THAP11, whose binding is required for the re-
cruitment of HCF-1 binds directly to the “upstream”
ACTACR module of the M4 motif. Conversely, Ikaros
interacts with the “downstream” module (YCCCR) and
is either directly or indirectly responsible for the associ-
ation of the Rel family TFs NFKB1 (p50) and NFKB2
(p52). As discussed above other TFs like STAF/ZNF143
and RBP-J (recruiting activated Notch1-ICN1) [9]
whose binding sites do also comprise the “down-
stream” module YCCCR would also bind to M4 in
non-lymphoid cells.
Methods
M4 motif bearing DNA ligand preparation
100 nM sense 5 prime biotinylated oligonucleotide (syn-
thesized by Eurofins MWG Operon) bearing either wild-
type or mutant M4 motif were combined with 110 nM
anti-sense oligonucleotide in 200 ul 20 mM Tris-HCl,
pH 8.0, 200 mM NaCl, 0.5 mM EDTA, 0.03 % NP40.
The reaction mixture was heated at 95 °C for 5 min and
then cooled down in a stepwise manner to 65 °C over
15 min, and kept at 65 °C for 5 min before the reaction
is allowd to be cooled to RT. At this point, the annealed
double stranded oligo-nucleotide can either be stored at
− 20 °C for long-term use or used in the following step.
Immobilization of biotinylated oligonucleotide to the
beads
100 μl suspension of Dyanabeads® Myone Streptavidin
bead (Dynal Biotech ASA, Oslo, Norway) was combined
with 13 μl annealed M4 motif bearing DNA ligand in
400 μl 20 mM Tris-HCl, pH 8.0, 200 mM NaCl, 0.5 mM
EDTA, 0.03 % NP40 for 3 h at room temperature and
then rotated at 4 °C overnight. Afterwards, the beads were
washed by three volumes of 800 μl 20 mM Tris-HCl,
pH 8.0, 200 mM NaCl, 0.5 mM EDTA, 0.03 % NP40 buf-
fer, and re-suspended in 100 μl of the same buffer. At this
point, the concentration of DNA ligand on bead sus-
pension was approximately 2.73 nM and could be
stored at 4 °C for later use.
One step-DNA affinity chromatography
The human T lymphoblastic leukemia Molt 4 or Raji
burkitt’s lymphoma cells were metabolically labeled in a
RPMI medium supplemented with either light or heavy
isotopes of two essential amino acids (1H4 lysine and
12C6 arginine) or (
2H4 lysine and
13C6 arginine) or just
(2H4 lysine) as described before [34]. After five doubling
cycles, the cells were expected to be more than 98 % iso-
topically-encoded. Two separate populations of isotope-
encoded cells were equally expanded to 5 l of 1 × 106 cell/
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ml and subjected for crude nuclear extract preparation.
The crude nuclear extract was then dialyzed at 4 °C against
a buffer (20 mM Tris-HCl, pH 7.3 containing 100 mM
KCl, 20 % glycerol and fresh protease/phosphates inhibi-
tors) and frozen in liquid nitrogen for further use.
Three volumes of crude nuclear extract from 1.5x108
cells were then incubated with three vials of magnetic
beads immobilized with 40nM M4 motif DNA ligand in
the buffer (20 mM Tris-HCl, pH 7.3 containing 100 mM
KCl, 10 % glycerol and fresh protease/phosphates inhibi-
tors) for 4 h, rotating at 4 °C. After washing away the
unbound materials, protein-DNA complexes were then
librated by PstI endonuclease restriction digestion.
Liquid chromatography mass spectrometry
Proteins eluted from the DNA affinity columns were re-
solved through 4–12 % Bis-Tris SDS gels (NuPAGE,
Invitrogen) and stained with colloidal Coomassie. The gels
were sliced into 10 equally sized gel pieces and subjected to
tryptic in-gel digestion [35]. Prior to LC-MS analysis, tryptic
peptide mixtures were desalted using STAGE tips (Empore
high performance extraction disks C18–IVA Anlysentech-
nik e. K Meerbusch, Germany) as described previously [36]
and the pooled elutates from the C18 tips were subse-
quently analyzed by nanoscale-LC (Agilent 1200 nanoflow
system), coupled either to a Hybrid LTQ OrbitrapXL or
LTQ-FTUltra mass spectrometer (Thermo Fisher Scientific
Inc. Bremen, Germany).
Peptides were eluted from an analytical column by a
linear gradient running from 5 to 80 % (v/v) acetonitrile
(in 0.5 % acetic acid) with a flow rate of 250 nl/min in
120 min gradient and sprayed directly into the orifice of
the mass spectrometer. The 15 cm fused silica emitter
with an inner diameter of 75 μm (New Objective, USA)
was packed in-house with reverse phase ReproSil-Pur
C18–AQ 3 μm resin (Dr. Maisch GmbH, Germany).
Data dependent acquisition of MS, MS/MS was per-
formed: Fullscan MS spectra (m/z 350–1600) were ac-
quired in the Orbitrap detector with resolution R = 60,000
at m/z = 400 with a target value of 1,000,000 ions allowing
a maximum injection-time of 1200 ms. The five most in-
tense ions were sequentially isolated for SIM (selected ion
monitoring), within an isolation width of 2.0 and a target
accumulation value of 50,000 (maximum fill-time =
500 ms). 30,000 ions were fragmented in the linear
ion trap by CID (collision induced dissociation) at a
target value of 10,000 (maximum fill-time = 50 ms).
Target ions selected for MS2 were dynamically excluded
for 180 s. The general mass spectrometric conditions
were: spray voltage, 2.4 kV; no sheath and auxiliary gas
flow; capillary temperature, 120 °C; normalized collision
energy 35.0, Ion selection thresholds were 500 counts for
MS2. An activation q = 0.25 and activation time of 30 ms
was applied for MS2 acquisition.
Data analysis
The raw Orbitrap MS files were processed with MSQuant
v2.0b5 and MaxQuant v1.0.12.31 [37, 38] two powerful
computational platform for SILAC based quantitative pro-
teomics, using the following settings: Enzyme specificity
was set to trypsin, allowing two total missed cleavages, at
N-terminal to proline segments, and between aspartic acid
and proline. Carbamidomethylation of cysteine were set as
a fixed modification, while methionine oxidation, protein
N-acetylation, and loss of ammonia from glutamine and
asparagine were set at variable modifications. The peak
lists generated by MaxQuant were searched with an in-
house Mascot 2.2 server against the human international
protein index (IPI) database (v.3.64) containing fre-
quently observed contaminants concatenated with a
decoy of the reversed sequences. For monoisotopic pre-
cursor ions, the maximum allowed mass deviation was set
to 5 ppm and for MS/MS peaks to 0.5 Da. The identified
proteins and peptides were further processed with Max-
Quant (imported as Mascot .dat files) with a minimum re-
quired peptide length of six amino acids and a false
discovery rate setting of 0.01 at the protein level. For pro-
tein identification and quantification, two unique peptides
and two quantified peptides were necessary. Before statis-
tical analysis, known contaminants were removed.
Ectopic expression retroviral transduced cell lines
Human cDNA coding for Ikaros was tagged at N ter-
minal with a StrepII-tandem-tag or HA epitope; the HA
epitope was also used to tag cDNA sequence coding for
human THAP11 at its C-terminal. These two chimeric
cDNA were PCR cloned into pMXs-IP retrovirus plas-
mid [39] (the primers used for cloning could be found in
supplimentary study data) and used for generating the
stable cell line Molt4-Strep-flag-Ikaros or Molt4-Ikaros-
HA or Molt4-THAP11-HA cell lines as describling pre-
viously [39, 40].
Chromatin immunoprecipitation
50 ml Molt4 cell aliquots of 5×105cells/ml were treated
with 1 % formaldehyde (final concentration) at RT for
5 min and then with 10 mM Disuccinimidyl glutarate
(final concentration) for another 2 min at RT. The
cross-linked cells were then washed 3 times with cold
PBS and resuspended in 850 μl cold-L1 lysis buffer
(50 mM Tris–HCl, pH 8.0, 2 mM EDTA, 0.1 % NP40,
10 % Glycerol, 2 mM fresh DTT, fresh protease inhibi-
tors, fresh phosphatase inhibitors, 1 mM sodium butyr-
ate) for 10 min on ice. The cells were spun down at
800×g for 5 min to clear out the cytoplasm fraction
(supernatant) and the pellet (cross-linked nuclei) were
re-suspended in 850 μl cold-L2 lysis buffer (50 mM
Tris-HCl, pH 8.0, 2 mM EDTA, 1 % SDS, 2 mM fresh
DTT, fresh protease inhibitors, fresh phosphatase
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inhibitors, sodium butyrate). At this point, the cross-
linked nuclei can be snapped down in liquid nitrogen
and stored at − 80 °C. Otherwise, the procedure can be
continued by sonifying the cross-linked nuclei, shearing
the chromatin into pieces of 300–1000 bp length, and
used as the input for immune-precipitation:
The sheared chromatin amount corresponding to one
aliquot of cross-linked nuclei (2.5 × 106 cells) was then
diluted 10 times into 1.5 ml DB buffer (50 mM Tris-
HCl, pH 8, 5 mM EDTA, 200 mM NaCl, 0.5 % NP40,
2 mM fresh DTT, fresh protease inhibitors, fresh phos-
phatase inhibitors, sodium butyrate) and incubated with
2.5.0 μg rabbit Ikaros antibody [41] or rat anti-HA anti-
body (3 F10 clone-Roche) which target the HA epitope
of Ikaros or THAP11 protein or HCF-1 antibody [10], or
NFkB p50 antibody (H-119-Santa Cruz Biotech) or
NFkB p52 antibody (C-5-Santa Cruz Biotech) or the in-
house raised rat monoclonal antibody that targets an
epitope at the C-terminus of THAP11 protein for 5 h.
The control assay was carried out at the same time using
2.5 μg rabbit pre-immune-serum and equal amounts of
input material. The DNA-protein complexes were pre-
cipitated by adding 30-40 μl salmon sperm, saturated
with protein G. The incubation time was extended for
45 min and the beads were then washed three times
with a NaCl washing buffer (20 mM Tris-HCl, pH 8,
2 mM EDTA, 500 mM NaCl, 1 % NP40, 1 % SDS) and
once with a LiCl washing buffer (20 mM Tris-HCl,
pH 8, 2 mM EDTA, 500 mM LiCl, 1 % NP40, 1 % SDS).
The G protein bound materials were released by incu-
bating with 2 volumes of 150 μl 20 mM Tris-HCl buffer
pH8 containing 2 % SDS and 0.5 mM EDTA for 5 min
at 65 °C. The released IP DNA was purified by using a
Qiagen PCR cleaning kit and stored in 250 μl 20 mM
Tris-HCl buffer pH8 0.5 mM EDTA at − 20 °C for later
realtime qPCR analysis.
Realtime qPCR analysis
2 μl of IP DNA or input DNA was templated for sybr-
green-based-realtime-qPCR reactions using primer pairs
as indicated in Table 1. Enrichment ratios of individual
M4 motif bearing promoters were calculated by normal-
izing the qPCR signal from IP DNA templates against
the signal from corresponding input genomics DNA.
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